Rajesh Kumar Galimudi

Rajesh Kumar Galimudi

Auto-generated profile, based on publicly available information

Rajesh Kumar Galimudi

Department of Genetics & Biotechnology, Osmania University, Hyderabad, Telangana, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CPChiranjeevi Padala
Chiranjeevi Padala
MTMohini Aiyengar Tupurani
Mohini Aiyengar Tupurani
KPKaushik Puranam
Kaushik Puranam
SGSrilatha Gantala
Srilatha Gantala
NSNivas Shyamala
Nivas Shyamala
SHSurekha Rani Hanumanth
Surekha Rani Hanumanth
Extracellular matrix degradation by matrix metalloproteinases (MMPs) is an important mechanism involved in tumor invasion and metastasis. Genetic variations of MMPs have shown association with multiple cancers. The present study is focused to elucidate the association of MMP-1, 3 and 9 genetic variants with respect to epidemiological and clinicopathological variables by haplotype, LD, MDR, survival in silico analyses among South Indian women. MMP3–1171 5A/6A and MMP9–1562 C/T SNPs were genotyped by Allele specific polymerase chain reaction and MMP1-1607 1G/2G polymorphism by restriction fragment length polymorphism assays respectively, in 300 BC patients and age-matched 300 healthy controls. Statistical analysis was performed using the SNPStats and SPSS software. Linkage disequilibrium and gene-gene interactions were performed using Haploview and MDR software respectively. Further, transcription factor binding sites in the promoter regions of SNPs under study were carried out using AliBaba2.1 software. We have observed an increased frequency of 2G-allele of MMP1, 6A-allele of MMP3 and T-allele of MMP9 (p<0.05) respectively in BC subjects. The 2G-6A haplotype (minor alleles of MMP-1 and MMP-3 respectively) has shown an increased susceptibility to BC. Further, MMP polymorphisms were associated with the clinical characteristics of BC patients such as steroid hormone receptor status, lymph node involvement and metastasis. SNP combinations were in perfect LD in controls. MDR analysis revealed a positive interaction between the SNPs. 5-years survival rate and cox-regression analysis showed a significant association with clinicopathological variables. Our results suggest that MMP1–1607 1G/2G, MMP3–1171 5A/6A and MMP9–1562 C/T gene polymorphisms have synergistic effect on breast cancer. The interactions of MMPs clinical risk factors such as lymph node involvement has shown a strong correlation and might influence the 5-years survival rate, suggesting their potential role in the breast carcinogenesis.

27 September 2013 in Inflammation
Verified
Journal Article
Closed access
PDF file
RGRajesh Kumar Galimudi
Rajesh Kumar Galimudi
MSMrudula K. Spurthi
Mrudula K. Spurthi
CPChiranjeevi Padala
Chiranjeevi Padala
KKKishore G. Kumar
Kishore G. Kumar
SMSaraswati Mudigonda
Saraswati Mudigonda
SHSurekha Rani Hanumanth
Surekha Rani Hanumanth

30 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RGRajesh Kumar G
Rajesh Kumar G
MKMrudula Spurthi K
Mrudula Spurthi K
KGKishore Kumar G
Kishore Kumar G
MKMohanalatha Kurapati
Mohanalatha Kurapati
SMSaraswati M
Saraswati M
SHSurekha Rani Hanumanth
Surekha Rani Hanumanth
Coronary Artery Disease (CAD) is clearly a multifactorial disease that develops from childhood and ultimately leads to death. Several reports revealed having a First Degree Relatives (FDRS) with premature CAD is a significant autonomous risk factor for CAD development. C - reactive protein (CRP) is a member of the pentraxin family and is the most widely studied proinflammatory biomarker. IL-18 is a pleiotrophic and proinflammatory cytokine which is produced mainly by macrophages and plays an important role in the inflammatory cascade. Hs-CRP levels were estimated by ELISA and Genotyping of IL-18 gene variant located on promoter -137 (G/C) by Allele specific PCR in blood samples of 300 CAD patients and 300 controls and 100 FDRS. Promoter Binding sites and Protein interacting partners were identified by Alibaba 2.1 and Genemania online tools respectively. Hs-CRP levels were significantly high in CAD patients followed by FDRS when compared to controls. In IL-18 -137 (G/C) polymorphism homozygous GG is significantly associated with occurrence of CAD and Hs-CRP levels were significantly higher in GG genotype subjects when compared to GC and CC. IL-18 was found to be interacting with 100 protein interactants. Our results indicate that Hs-CRP levels and IL-18-137(G/C) polymorphism may help to identify risk of future events of CAD in asymptomatic healthy FDRS.

1 October 2018 in Gene
Verified
Journal Article
Closed access
SGSrilatha Reddy Gantala
Srilatha Reddy Gantala
MKMrudula Spurthi Kondapalli
Mrudula Spurthi Kondapalli
RKRamanjaneyulu Kummari
Ramanjaneyulu Kummari
CPChiranjeevi Padala
Chiranjeevi Padala
MTMohini Aiyengar Tupurani
Mohini Aiyengar Tupurani
SHSurekha Rani Hanumanth
Surekha Rani Hanumanth

13 July 2018 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
JVJose Manuel Valdivielso
Jose Manuel Valdivielso
MBMilica Bozic
Milica Bozic
RGRajesh Kumar Galimudi
Rajesh Kumar Galimudi
MBMarcelino Bermúdez-López
Marcelino Bermúdez-López
JNJuan Navarro-Gonzalez
Juan Navarro-Gonzalez
ÀBÀngels Betriu
Àngels Betriu
Background: Prevalence of atherosclerotic cardiovascular disease and its rate of progression are higher in patients with chronic kidney disease (CKD) compared with the general population. Mineral metabolism parameters have been shown to be involved in the increased velocity of atheromatosis progression. The aim of this study is to determine the role of 11 single-nucleotide polymorphisms (SNPs) of the Klotho gene on the rate of atherosclerosis progression in CKD. Methods: This was a multicentre, prospective, observational study of 1439 CKD patients from the NEFRONA cohort. Carotid and femoral ultrasounds were performed at baseline and after 24 months in 10 arterial territories. Progression of atheromatosis was defined as an increase in the number of territories with plaque. Genotyping of 11 SNPs of the Klotho gene was performed and its association with atheromatosis progression was determined by multivariate logistic regression. Results: Bivariate analysis showed that none of the 11 SNPs was associated with atheroma plaque prevalence, but 3 of them (rs495392, rs562020 and rs567170) showed association with atheromatosis progression. The multivariate analysis revealed that only rs495392 showed a statistically significant association with atheromatosis progression, after adjustment for several parameters known to affect it in CKD patients. Thus, the presence of one allele T was associated with a reduction of 30% of the odds of progression, whereas the presence of the two T alleles was associated with a decrease close to 50%. Conclusions: The presence of the allele T of the SNP rs495392 of the Klotho gene is associated with a decrease in the odds of progression of atheromatosis in CKD patients.

1 November 2016 in Nitric Oxide
Verified
Journal Article
Closed access
GKGalimudi Rajesh Kumar
Galimudi Rajesh Kumar
KSKondapalli Mrudula Spurthi
Kondapalli Mrudula Spurthi
GKGundapaneni Kishore Kumar
Gundapaneni Kishore Kumar
TATupurani Mohini Aiyengar
Tupurani Mohini Aiyengar
PCPadala Chiranjeevi
Padala Chiranjeevi
SHSurekha Rani Hanumanth
Surekha Rani Hanumanth